Barinthus Biotherapeutics (BRNS) Interest & Investment Income (2021 - 2026)
Barinthus Biotherapeutics (BRNS) reported Interest & Investment Income of $350000.0 for Q1 2026, down 37.05% on a YoY basis from $556000.0 in Q1 2025, and down 13.79% quarter-over-quarter from $406000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Interest & Investment Income (2021 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Interest & Investment Income for 6 years, with the latest figure at $350000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 37.05% year-over-year to $350000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 28.79% YoY), and the FY2025 full-year result was $2.0 million, down 26.92% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $350000.0, down from $406000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.6 million in Q1 2023, with the low at $83000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $645000.0 across 5 years, with a median of $571000.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 4050.0% — and 2023, when it tumbled 80.86%.
- Barinthus Biotherapeutics' Interest & Investment Income stood at $1.3 million in 2022, then tumbled by 56.97% to $571000.0 in 2023, then advanced by 11.56% to $637000.0 in 2024, then plunged by 36.26% to $406000.0 in 2025, then dropped by 13.79% to $350000.0 in 2026.
- The last three Interest & Investment Income figures came in at $350000.0 (Q1 2026), $406000.0 (Q4 2025), and $472000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | 350,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 350,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 523,000.00 |
| Mar 31, 2025 | 556,000.00 |
| Dec 31, 2024 | 637,000.00 |
| Sep 30, 2024 | 631,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 775,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 522,000.00 |
| Mar 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 669,000.00 |
| Mar 31, 2022 | 83,000.00 |
| Mar 31, 2021 | 2,000.00 |